0001178913-26-001722
SEC filingSilexion Therapeutics Corp's Board of Directors removed Ilan Levin from his position as a member of the Board, effective immediately on March 25, 2026. The removal was effected via a unanimous written determination by all other Board members pursuant to Article 28.7 of the Company’s Amended and Restated Articles of Association.